Essity Earnings: Profit Delivery Ahead of Expectations and Encouraging Portfolio Initiatives
No-moat Essity ESSITY B delivered strong first-quarter results, with organic sales growth of 16% (25% reported, with an 8% currency benefit) and a 200-basis-point improvement in adjusted operating profit margin to 9.5% in the quarter. Operating margin recovery is tracking ahead of our expectations after the significant drop experienced last year, with pricing actions catching up with raw material, energy, and distribution cost inflation in the quarter. As this is expected to sequentially improve in the coming quarters, especially for the consumer goods segment, we increase our 2023 EBIT margin forecast to 10% from 8.5% previously. Our long-term margin forecast remains unchanged, calling for a steady-state operating margin of around 13% for the group. The improved short-term margin outlook, together with our expectation for heftier 2023 net sales (167 billion SEK compared with 160 billion SEK previously, driven by the first quarter results and more resilient volume development expected for the full year) lead us to increase our fair value estimate by 10% to SEK 260. Still, we view shares as expensive at current levels, trading in the 2-star territory.
Essity also announced a strategic review aimed at reducing its exposure to the commoditized consumer tissue segment. To this end, it’s reviewing its ownership of the Asian hygiene company Vinda (of which Essity owns 51.59% and consolidates 100%) and the consumer tissue private label business in Europe. Together these two segments accounted for about 22% of Essity’s 2022 net sales. We regard this initiative as positive for the company’s long-term prospects, as it could potentially allow management to focus on some of the faster-growing and more differentiated segments, such as intimate hygiene. However, we don’t expect to see a divestment decision in the near future, with management committed to maximize value for investors, which we believe will be difficult in the current volatile market environment.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.